ArticleCancers2024

The Novel HDAC Inhibitor OBP-801 Promotes MHC Class I Presentation Through LMP2 Upregulation, Enhancing the PD-1-Targeting Therapy in Clear Cell Renal Cell Carcinoma.

Tsukasa Narukawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.